Diterpenes: Advances in Neurobiological Drug Research

A significant number of studies have been performed with diterpene effect on the brain. Our study aims to make a systematic revision on them. The initial purpose of this review was to screen diterpenes with neurological activity, in particular those that have already been studied and published in different journals (databases until August 2015). The second purpose was to make an action‐wise discussion as results viewed on them by taking into drug discovery and development account. Diterpenes considered in this review were selected on the basis of updated information on them and having sufficient information on their screenings. We identified several examples of diterpenes having an interest in further study. We have included the possible sources of them as observed in evidence, their known molecular neurobiological mechanisms, and the active constituents responsible for such activities with the doses and test systems. Results suggest diterpenes to have neurobiological activities like neuro‐protection, anti‐epileptic, anxiolytic, anti‐Alzheimer's disease, anti‐Parkinson's disease, anti‐cerebral ischemia, anti‐neuropathic pain, anti‐neuro‐inflammatory, and many more. In conclusion, diterpenes may be the prominent candidates in neurobiological drug research. Copyright © 2016 John Wiley & Sons, Ltd.

[1]  K. Nieber.  The Impact of Coffee on Health , 2017, Planta Medica.

[2]  Y. Shi,et al.  Tanshinone IIA protects dopaminergic neurons against 6-hydroxydopamine-induced neurotoxicity through miR-153/NF-E2-related factor 2/antioxidant response element signaling pathway , 2015, Neuroscience.

[3]  Simona Birtić,et al.  Carnosic acid. , 2015, Phytochemistry.

[4]  K. Itoh,et al.  Carnosic acid attenuates apoptosis induced by amyloid-β 1–42 or 1–43 in SH-SY5Y human neuroblastoma cells , 2015, Neuroscience Research.

[5]  M. Ravalji.  Pathobiology of neuropathic pain , 2015 .

[6]  Chi-Rei Wu,et al.  Carnosic acid protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson's disease: involvement of antioxidative enzymes induction. , 2015, Chemico-biological interactions.

[7]  M. Hamburger,et al.  Identification of dehydroabietc acid from Boswellia thurifera resin as a positive GABAA receptor modulator. , 2014, Fitoterapia.

[8]  E. G. Mejia,et al.  Impact of caffeine and coffee on our health , 2014, Trends in Endocrinology & Metabolism.

[9]  Jae-Hoon Bae,et al.  Coffee and health , 2014, Integrative medicine research.

[10]  E. Yang,et al.  Andrographolide, a major component of Andrographis paniculata leaves, has the neuroprotective effects on glutamate-induced HT22 cell death , 2014 .

[11]  Jing Xu,et al.  Two novel clerodane diterpenenes with NGF-potentiating activities from the twigs of Croton yanhuii. , 2014, Fitoterapia.

[12]  H. J. Woerdenbag,et al.  Jamu: Indonesian traditional herbal medicine towards rational phytopharmacological use , 2014 .

[13]  Jéssica Pereira Costa,et al.  Anxiolytic-like effects of phytol: Possible involvement of GABAergic transmission , 2014, Brain Research.

[14]  K. Itoh,et al.  Carnosic acid suppresses the production of amyloid-β 1-42 and 1-43 by inducing an α-secretase TACE/ADAM17 in U373MG human astrocytoma cells , 2014, Neuroscience Research.

[15]  S. Lipton,et al.  Reprint of: Nrf2/ARE-mediated antioxidant actions of pro-electrophilic drugs. , 2014, Free radical biology & medicine.

[16]  M. Hamburger,et al.  Phytochemical profiling of Curcuma kwangsiensis rhizome extract, and identification of labdane diterpenoids as positive GABAA receptor modulators. , 2013, Phytochemistry.

[17]  R. Tundis,et al.  Chemistry and functional properties in prevention of neurodegenerative disorders of five Cistus species essential oils. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[18]  K. Oh,et al.  Reynosin protects against neuronal toxicity in dopamine-induced SH-SY5Y cells and 6-hydroxydopamine-lesioned rats as models of Parkinson's disease: Reciprocal up-regulation of E6-AP and down-regulation of α-synuclein , 2013, Brain Research.

[19]  Priyanka Singh,et al.  Structural modeling and simulation studies of human cyclooxygenase (COX) isozymes with selected terpenes: Implications in drug designing and development , 2013, Comput. Biol. Medicine.

[20]  A. Pittaluga,et al.  Effects of the neoclerodane Hardwickiic acid on the presynaptic opioid receptors which modulate noradrenaline and dopamine release in mouse central nervous system , 2013, Neurochemistry International.

[21]  O. Hwang.  Role of Oxidative Stress in Parkinson's Disease , 2013, Experimental neurobiology.

[22]  E. González-Burgos,et al.  Involvement of Nrf2 signaling pathway in the neuroprotective activity of natural kaurane diterpenes , 2013, Neuroscience.

[23]  Lei Chen,et al.  Ginkgolide B preconditioning on astrocytes promotes neuronal survival in ischemic injury via up-regulating erythropoietin secretion , 2013, Neurochemistry International.

[24]  B. Dell’Osso,et al.  Do Benzodiazepines Still Deserve a Major Role in The Treatment of Psychiatric Disorders? A Critical Reappraisal , 2013, European Psychiatry.

[25]  C. Won,et al.  Coffee Consumption and Stroke Risk: A Meta-analysis of Epidemiologic Studies , 2012, Korean journal of family medicine.

[26]  W. Harding,et al.  Leonurenones A-C: Labdane diterpenes from Leonotis leonurus. , 2012, Phytochemistry.

[27]  J. Rojas-Castañeda,et al.  Effect of a phytopharmaceutical medicine, Ginko biloba extract 761, in an animal model of Parkinson's disease: therapeutic perspectives. , 2012, Nutrition.

[28]  J. Xiong,et al.  Chemical constituents from the submerged plant Potamogeton crispus and.. their effects on NAD（P）H：quinone oxidoreductase 1 , 2012 .

[29]  J. Logomarsino,et al.  Impact of coffee components on inflammatory markers: A review , 2012 .

[30]  J. Jordán,et al.  Anticonvulsant effect of phytol in a pilocarpine model in mice , 2012, Neuroscience Letters.

[31]  A. Ebrahimi,et al.  Natural polyphenols against neurodegenerative disorders: Potentials and pitfalls , 2012, Ageing Research Reviews.

[32]  Jin-Ming Gao,et al.  Scabronine M, a novel inhibitor of NGF-induced neurite outgrowth from PC12 cells from the fungus Sarcodon scabrosus. , 2012, Bioorganic & medicinal chemistry letters.

[33]  R. Stevens,et al.  Structure of the human kappa opioid receptor in complex with JDTic , 2012, Nature.

[34]  Ying-wei Wang,et al.  Intrathecal administration of triptolide, a T lymphocyte inhibitor, attenuates chronic constriction injury-induced neuropathic pain in rats , 2012, Brain Research.

[35]  B. Cohen,et al.  Differential signaling properties at the kappa opioid receptor of 12-epi-salvinorin A and its analogues. , 2012, Bioorganic & medicinal chemistry letters.

[36]  Ajmal Ahmad,et al.  Rutin Protects Dopaminergic Neurons from Oxidative Stress in an Animal Model of Parkinson’s Disease , 2011, Neurotoxicity Research.

[37]  S. Larsson,et al.  Coffee consumption and risk of stroke: a dose-response meta-analysis of prospective studies. , 2011, American journal of epidemiology.

[38]  G. Bernardi,et al.  l-DOPA: A scapegoat for accelerated neurodegeneration in Parkinson's disease? , 2011, Progress in Neurobiology.

[39]  M. Medina,et al.  Anti-Angiogenic and Anti-Inflammatory Properties of Kahweol, a Coffee Diterpene , 2011, PloS one.

[40]  Jing Xu,et al.  Neuroprotective labdane diterpenes from Fritillaria ebeiensis. , 2011, Fitoterapia.

[41]  T. Müller.  Motor complications, levodopa metabolism and progression of Parkinson's disease , 2011, Expert opinion on drug metabolism & toxicology.

[42]  N. Azad,et al.  Neuroprotective Effects of Carnosic Acid in an Experimental Model of Alzheimer’s Disease in Rats , 2011, Cell journal.

[43]  I. Sousa,et al.  Geranylgeraniol and 6α,7β-dihydroxyvouacapan-17β-oate methyl ester isolated from Pterodon pubescens Benth.: Further investigation on the antinociceptive mechanisms of action. , 2011, European journal of pharmacology.

[44]  J. Sareen,et al.  Prevalence and correlates of generalized anxiety disorder in a national sample of older adults. , 2011, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[45]  M. Marder,et al.  Central nervous system activities of two diterpenes isolated from Aloysia virgata. , 2011, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[46]  C. Ferrari,et al.  Parkinson's Disease and Systemic Inflammation , 2011, Parkinson's disease.

[47]  A. A. Farooqui,et al.  Lipid-Mediated Oxidative Stress and Inflammation in the Pathogenesis of Parkinson's Disease , 2011, Parkinson's disease.

[48]  N. Plesnila,et al.  Bid-mediated mitochondrial damage is a key mechanism in glutamate-induced oxidative stress and AIF-dependent cell death in immortalized HT-22 hippocampal neurons , 2011, Cell Death and Differentiation.

[49]  M. Nair,et al.  Labdane diterpenes in Curcuma mangga rhizomes inhibit lipid peroxidation, cyclooxygenase enzymes and human tumour cell proliferation , 2011 .

[50]  T. Ishrat,et al.  Neuroprotective effects of curcumin on 6-hydroxydopamine-induced Parkinsonism in rats: Behavioral, neurochemical and immunohistochemical studies , 2011, Brain Research.

[51]  K. Sawada,et al.  Design, synthesis, and characterization of BK channel openers based on oximation of abietane diterpene derivatives. , 2010, Bioorganic & medicinal chemistry.

[52]  S. Morgan,et al.  Patterns in the use of benzodiazepines in British Columbia: examining the impact of increasing research and guideline cautions against long-term use. , 2010, Health policy.

[53]  B. Hwang,et al.  The new diterpene isodojaponin D inhibited LPS-induced microglial activation through NF-kappaB and MAPK signaling pathways. , 2010, European journal of pharmacology.

[54]  P. Shaw,et al.  Interaction study of two diterpenes, cryptotanshinone and dihydrotanshinone, to human acetylcholinesterase and butyrylcholinesterase by molecular docking and kinetic analysis. , 2010, Chemico-biological interactions.

[55]  T. Jensen,et al.  The evidence for pharmacological treatment of neuropathic pain , 2010, PAIN.

[56]  J. van Staden,et al.  In vitro biological activities of niloticane, a new bioactive cassane diterpene from the bark of Acacia nilotica subsp. kraussiana. , 2010, Journal of ethnopharmacology.

[57]  W. Klein,et al.  A Mouse Model of Amyloid β Oligomers: Their Contribution to Synaptic Alteration, Abnormal Tau Phosphorylation, Glial Activation, and Neuronal Loss In Vivo , 2010, The Journal of Neuroscience.

[58]  T. Rohn.  The role of caspases in Alzheimer’s disease; potential novel therapeutic opportunities , 2010, Apoptosis.

[59]  N. Gomes,et al.  Plants with neurobiological activity as potential targets for drug discovery , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[60]  B. Hwang,et al.  Neuroprotective effects of the new diterpene, CBNU06 against beta-amyloid-induced toxicity through the inhibition of NF-kappaB signaling pathway in PC12 cells. , 2009, European journal of pharmacology.

[61]  A. Pittaluga,et al.  Salvinorin A exerts opposite presynaptic controls on neurotransmitter exocytosis from mouse brain nerve terminals , 2009, Neuropharmacology.

[62]  Cécile Béguin,et al.  Kappa-opioid ligands in the study and treatment of mood disorders. , 2009, Pharmacology & therapeutics.

[63]  Won‐Kyo Jung,et al.  Inhibitory effects and molecular mechanism of dieckol isolated from marine brown alga on COX-2 and iNOS in microglial cells. , 2009, Journal of agricultural and food chemistry.

[64]  U. Dirnagl,et al.  Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use , 2009, The Lancet Neurology.

[65]  C. Matute,et al.  Molecular mechanisms of neuroprotection by two natural antioxidant polyphenols. , 2009, Cell calcium.

[66]  W. Xu,et al.  Synthesis and biological evaluation of C-12 triazole and oxadiazole analogs of salvinorin A. , 2009, Bioorganic & medicinal chemistry letters.

[67]  R. Rothman,et al.  Synthetic studies of neoclerodane diterpenoids from Salvia splendens and evaluation of Opioid Receptor affinity. , 2008, Tetrahedron.

[68]  Yun-yu Hu,et al.  Neurotrophin-3 reduces apoptosis induced by 6-OHDA in PC12 cells through Akt signaling pathway , 2008, International Journal of Developmental Neuroscience.

[69]  E. Butelman,et al.  The Effects of Herkinorin, the First μ-Selective Ligand from a Salvinorin A-Derived Scaffold, in a Neuroendocrine Biomarker Assay in Nonhuman Primates , 2008, Journal of Pharmacology and Experimental Therapeutics.

[70]  Y. Hwang,et al.  The coffee diterpene kahweol induces heme oxygenase‐1 via the PI3K and p38/Nrf2 pathway to protect human dopaminergic neurons from 6‐hydroxydopamine‐derived oxidative stress , 2008, FEBS letters.

[71]  W. Yeh,et al.  LPS/TLR4 signal transduction pathway. , 2008, Cytokine.

[72]  S. Greenwood,et al.  Dendritic and mitochondrial changes during glutamate excitotoxicity , 2007, Neuropharmacology.

[73]  A. Akaike,et al.  Synthesis and pharmacological profile of serofendic acids A and B. , 2007, Bioorganic & medicinal chemistry.

[74]  Dan J Stein,et al.  Emerging anxiolytics , 2007, Expert opinion on emerging drugs.

[75]  H. Jeong,et al.  Protective effects of kahweol and cafestol against hydrogen peroxide-induced oxidative stress and DNA damage. , 2007, Toxicology letters.

[76]  Y. Obara,et al.  A novel cyathane diterpene, cyrneine A, induces neurite outgrowth in a Rac1-dependent mechanism in PC12 cells. , 2007, Life sciences.

[77]  H. Chun,et al.  Quantitative structure-activity relationship (QSAR) for neuroprotective activity of terpenoids. , 2007, Life sciences.

[78]  D. Dickson,et al.  Filling the Gaps in the Aβ Cascade Hypothesis of Alzheimers Disease , 2006 .

[79]  Lloyd A Greene,et al.  RTP801 Is Elevated in Parkinson Brain Substantia Nigral Neurons and Mediates Death in Cellular Models of Parkinson's Disease by a Mechanism Involving Mammalian Target of Rapamycin Inactivation , 2006, The Journal of Neuroscience.

[80]  Alun Williams,et al.  Platelet-activating factor antagonists protect amyloid-β damaged neurons from microglia-mediated death , 2006, Neuropharmacology.

[81]  Mingxing Ouyang,et al.  Critical role of ASK1 in the 6‐hydroxydopamine‐induced apoptosis in human neuroblastoma SH‐SY5Y cells , 2006, Journal of neurochemistry.

[82]  B. Frei,et al.  Coffee and Health: A Review of Recent Human Research , 2006, Critical reviews in food science and nutrition.

[83]  C. Piantadosi,et al.  A comparison of hyperbaric oxygen versus hypoxic cerebral preconditioning in neonatal rats , 2006, Brain Research.

[84]  E. Kojro,et al.  Alpha-secretase as a therapeutic target , 2005, Alzheimer's & Dementia.

[85]  N. Greig,et al.  Cholinesterases: roles in the brain during health and disease. , 2005, Current Alzheimer research.

[86]  S. Gandy,et al.  The role of cerebral amyloid β accumulation in common forms of Alzheimer disease , 2005 .

[87]  M. Hautzinger,et al.  A Meta-analytic Review of the Efficacy of Drug Treatment in Generalized Anxiety Disorder , 2005, Journal of clinical psychopharmacology.

[88]  T. Ranheim,et al.  Coffee consumption and human health--beneficial or detrimental?--Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and type 2 diabetes mellitus. , 2005, Molecular nutrition & food research.

[89]  K. Nakanishi,et al.  Preparation of a tritiated ginkgolide. , 2004, Bioorganic & medicinal chemistry letters.

[90]  C. DeCarli,et al.  Neutralization of Transthyretin Reverses the Neuroprotective Effects of Secreted Amyloid Precursor Protein (APP) in APPSw Mice Resulting in Tau Phosphorylation and Loss of Hippocampal Neurons: Support for the Amyloid Hypothesis , 2004, The Journal of Neuroscience.

[91]  M. Mattson.  Pathways towards and away from Alzheimer's disease , 2004, Nature.

[92]  K. Sasaki,et al.  Ginkgolides, diterpene trilactones of Ginkgo biloba, as antagonists at recombinant α1β2γ2L GABAA receptors , 2004 .

[93]  P. Passilly-Degrace,et al.  Quantification of Neurotrophin mRNA Expression in PMN Mouse: Modulation by Xaliproden , 2004, International journal of immunopathology and pharmacology.

[94]  Ling-Ling Yang,et al.  Differential effects of natural polyphenols on neuronal survival in primary cultured central neurons against glutamate- and glucose deprivation-induced neuronal death , 2003, Brain Research.

[95]  I. Liberzon,et al.  Role of the GABAA Receptor in Anxiety: Evidence from animal models, molecular and clinical psychopharmacology, and brain imaging studies , 2003 .

[96]  John X. Morris,et al.  A multicenter, randomized, placebo controlled, multiple-dose, safety and pharmacokinetic study of AIT-082 (Neotrofin) in mild Alzheimer's disease patients. , 2003, Life sciences.

[97]  Ling Li,et al.  Effects of spiramine T on antioxidant enzymatic activities and nitric oxide production in cerebral ischemia–reperfusion gerbils , 2002, Brain Research.

[98]  Á. Simonyi,et al.  The "French Paradox" and beyond: neuroprotective effects of polyphenols. , 2002, Free radical biology & medicine.

[99]  D. Allan Butterfield.  Amyloid β-peptide (1-42)-induced Oxidative Stress and Neurotoxicity: Implications for Neurodegeneration in Alzheimer's Disease Brain. A Review , 2002 .

[100]  Eduardo D. Martín,et al.  Synaptic regulation of the slow Ca2+-activated K+ current in hippocampal CA1 pyramidal neurons: implication in epileptogenesis. , 2001, Journal of neurophysiology.

[101]  B. Winblad,et al.  Quantitative autoradiography of [ 3 H ]forskolin binding sites in post-mortem brain staged for Alzheimer's disease neurofibrillary changes and amyloid deposits , 1999, Brain Research.

[102]  J. Treanor,et al.  Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. , 1999, Science.

[103]  R. Ritch,et al.  Ginkgo biloba extract increases ocular blood flow velocity. , 1999, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[104]  J. Fastbom,et al.  A quantitative autoradiographic study of [ 3 H ]cAMP binding to cytosolic and particulate protein kinase A in post-mortem brain staged for Alzheimer's disease neurofibrillary changes and amyloid deposits , 1999, Brain Research.

[105]  P. Jenner,et al.  Understanding cell death in parkinson's disease , 1998, Annals of neurology.

[106]  C D Marsden,et al.  Oxidative DNA Damage in the Parkinsonian Brain: An Apparent Selective Increase in 8‐Hydroxyguanine Levels in Substantia Nigra , 1997, Journal of neurochemistry.

[107]  W. Willett,et al.  A prospective study of coffee drinking and suicide in women. , 1996, Archives of internal medicine.

[108]  H. Doerr,et al.  Aphidicolin selectively kills neuroblastoma cells in vitro. , 1992, Cancer letters.

[109]  W. Löscher,et al.  Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations , 1988, Epilepsy Research.

[110]  R. Stevens,et al.  Structure of the human k-opioid receptor in complex with JDTic , 2012 .

[111]  M. Tansey,et al.  Delayed dominant-negative TNF gene therapy halts progressive loss of nigral dopaminergic neurons in a rat model of Parkinson's disease. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[112]  Forskolin and 8-cyclopentyltheophyline synergistically facilitate the neuronal activity in the CA2 area of rat hippocampus via caMP and non-caMP cascades. , 2007, Sheng li xue bao : [Acta physiologica Sinica].

[113]  B. Jayaprakasam,et al.  Terpenoids from Stinking toe (Hymneae courbaril) fruits with cyclooxygenase and lipid peroxidation inhibitory activities , 2007 .

[114]  Dong Hee Kim,et al.  Inhibitory effect of the coffee diterpene kahweol on carrageenan‐induced inflammation in rats , 2006, BioFactors.

[115]  P. Butko,et al.  Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[116]  A. Ulubelen,et al.  Chemical and biological evaluation of genus teucrium , 2000 .

[117]  J. Georgieva.  Influences of diterpene sclareol glycol on some dopamine related behavior. , 1991, General pharmacology.

[118]  E. Morrel,et al.  [Quantitative autoradiography]. , 1982, Acta histochemica. Supplementband.